Pfizer's (NYSE:PFE) stock up by 7.7% over the past three months. However, we decided to study the company's mixed-bag of ...

Pfizer Inc. (NYSE: PFE) announced today the completion of a global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK) ...

Pfizer (PFE) stock in focus as company faces lawsuits over its alleged failure to warn about brain tumor risks linked to Depo ...

Key Points Pfizer stands as one of the largest pharmaceutical companies in the world.Although it has an attractive 7.1% yield, it has a big blemish in its dividend past.Investors looking at drug ...

These five blue-chip dividend stocks have had a tough 2025 but are solid long-term buys for growth and income investors.

GSK (GSK) stock in focus as the company secures EU approval for Blenrep combo therapies targeting the blood cancer multiple ...

Lee, at this point in the year, all the companies that pay dividends have pretty much set their dividends. You know, the ...

It might be prudent to make a point of collecting a little more cash in the near future, and worry a little less about growth ...

Here are five high-yield dividend stocks that offer passive income and solid entry points that investors can buy and forget about forever.

Roche (OTCQX:RHHBY) (OTCQX:RHHBF) announced Thursday it has begun discussions with the U.S. government to launch ...

SmallCap stocks can often be overlooked by institutional investors, yet they offer outsized return potential for those ...

The exanthema market is projected to grow from USD 1.39 billion in 2024 to USD 2.51 billion by 2034 at a CAGR of 6.10%. This growth is driven by risi ...